Overview
Giovanni Borghi practices practicing medicine in Milan, Italy.
His clinical expertise encompasses Cerebral Hypoxia, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Acute Respiratory Distress Syndrome (ARDS).
He is actively involved in clinical research, co-authoring 35 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Giovanni Borghi
Is Giovanni Borghi a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Giovanni Borghi is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Giovanni Borghi participate in research or clinical trials?
Yes. Giovanni Borghi has published 35 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Giovanni Borghi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- Cerebral HypoxiaMr. Borghi isExperienced. Learn about Cerebral Hypoxia.
- COVID-19Mr. Borghi isExperienced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)